Generics Cos. Get More Freedom In High Court Patent Ruling
By Ryan Davis · June 4, 2026, 9:54 PM EDT
The U.S. Supreme Court's decision Thursday shutting down a patent case involving a generic heart drug that uses a so-called skinny label establishes a road map for generics companies to avoid...
To view the full article, register now.